Mikanisal

Ketoconazole, the active ingredient in Mikanisal, is an imidazole antifungal presented as an unknown strength/topical formulation for cutaneous use. It treats fungal skin infections such as athlete’s foot, ringworm, and seborrheic dermatitis in adults and children as directed by a healthcare professional.

GNH USA supplies Mikanisal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoconazole is applied topically to manage fungal skin conditions within the dermatophytic and yeast infection families.

- Tinea corporis: reduces fungal growth and clears ring‑shaped lesions on the body. - Tinea cruris: alleviates itching and erythema in the groin area caused by dermatophytes. - Tinea pedis: eliminates foot‑related fungal infection and restores normal skin texture. - Seborrheic dermatitis: controls Malassezia overgrowth, decreasing scaling and redness on scalp and face. - Pityriasis versicolor: eradicates yeast colonisation, improving skin discoloration.

Topical ketoconazole may cause local skin reactions ranging from mild irritation to rare severe events.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Stinging or tingling feeling. - Dryness or flaking of the skin. - Redness or mild erythema. - Contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, urticaria). - Extensive skin blistering or bullous dermatitis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic absorption leading to hepatic enzyme alterations (very rare with topical use).

When using Mikanisal, follow standard safety measures to minimise adverse reactions.

- Avoid application on broken or inflamed skin: limit use to intact areas. - Do not apply near eyes, mucous membranes, or genital mucosa. - Limit treatment duration to the period prescribed, typically no longer than two weeks unless advised. - Discontinue use and seek medical advice if severe irritation or allergic signs develop. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Topical ketoconazole has limited systemic interaction potential, but certain co‑applications may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use with other topical azole antifungals may increase local irritation. - Application over large surface areas combined with systemic ketoconazole can raise systemic exposure.

Moderate Interactions (Monitor Closely): - Use with potent topical corticosteroids may enhance percutaneous absorption. - Combining with sunscreen or oily moisturizers might reduce antifungal effectiveness. - Co‑application with other irritant skin products should be monitored for additive dermatitis risk.